TECX MEXC RealStocks
Own real TECX shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 13:09:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Tectonic Therapeutic, Inc. (TECX) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $21.97, with a market capitalization of $429.50M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $16.77 to $39.53. This page covers its latest market performance, valuation, price trends and company information.
$429.50M | |
$22.19 | |
$23.00 | |
$21.54 | |
$21.97 | |
120.40K | |
214.54K | |
-- | |
$39.53 | |
$16.77 | |
-- | |
-- |
Tectonic Therapeutic, Inc. (TECX) is trading at $22.39 in pre-market trading as of 2026-11-12 00:56:00, up 1.90% ($0.42) from the previous close of $21.97
Pre-market trading shows how investors are pricing TECX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, Tectonic Therapeutic, Inc. (TECX) moved from $18.98 to $21.97, representing a gain of 15.73% ($2.98).
The stock traded between $18.76 and $23.00 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 185.35 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 22.8%
TECX is currently trading at $21.97, placing it 22.8% of the way from its 52-week low of $16.77 to its 52-week high of $39.53. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 60 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Tectonic Therapeutic, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Tectonic Therapeutic, Inc. (TECX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to TECX, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between TECX shares and USD.
TECX Shares to USD
1.00 TECX shares = 21.965 USD
Calculations are estimates based on the latest available price and are for reference only.